4D pharma Presents Additional Positive Results of Phase II Study of Blautix® for the Treatment of Irritable Bowel SyndromeNew data demonstrating clinical activity in both IBS-C and IBS-D was presented at Digestive Disease Week 2021Company to host webcast on Tuesday, May 25, 2021 at 12:00 p.m. EDLeeds, UK, May 24.
4D pharma Presents Additional Positive Results of Phase II Study of Blautix® for the Treatment of Irritable Bowel Syndrome pharmiweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmiweb.com Daily Mail and Mail on Sunday newspapers.
4D pharma plc: 4D pharma Presents Additional Positive Results of Phase II Study of Blautix for the Treatment of Irritable Bowel Syndrome finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.